CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Opti-Free® RepleniSH® MPDS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00789529
NCT00789529N/ACompleted
CompareCT.gov

Objective Testing of Tear Film Stability

Manhattan Vision Associates·interventional·Posted Nov 13, 2008·Updated May 31, 2013

In Brief

A clinical study evaluating Opti-Free® RepleniSH® MPDS and ReNu MultiPlus® for Contact Lens Solutions. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the in-vivo wettability of soft contact lenses when cared with two different multi-purpose solutions over a two week wearing period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContact Lens Solutions
CountriesUnited States
CollaboratorsAlcon Research

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 13, 2008
Enrollment StartSep 1, 2008
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.6 years ago

Interventions

Opti-Free® RepleniSH® MPDSdevice

soft contact lens disinfecting solution

ReNu MultiPlus®device

soft contact lens disinfecting solution